Cargando…

Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study

OBJECTIVE: To compare the effects on feto-maternal outcomes of expectant versus active management for premature rupture of membranes (PROM) at term. METHODS: This was a prospective randomized (1:1) controlled study involving 86 pregnant-women who received either expectant management (n = 43) or acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Awkadigwe, Fredrick I., Ezugwu, Frank O., Eleje, George U., Nweze, Sylvester O., Odugu, Boniface U., Dinwoke, Victor O., Olu, Ephraim A., Ortuanya, Kelvin E., Ezenwaeze, Malachy N., Eze, Obiechina C., Onyekpa, Johnson I., Ofor, Ifeanyichukwu J., Onah, Osmond O., Omeje, Chimdalu U., Ezike, Andre U., Enyinna, Perpetua K., Malachy, Divinefavour E., Okafor, Chigozie G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478565/
https://www.ncbi.nlm.nih.gov/pubmed/37656970
http://dx.doi.org/10.1177/03000605231195451
_version_ 1785101380882530304
author Awkadigwe, Fredrick I.
Ezugwu, Frank O.
Eleje, George U.
Nweze, Sylvester O.
Odugu, Boniface U.
Dinwoke, Victor O.
Olu, Ephraim A.
Ortuanya, Kelvin E.
Ezenwaeze, Malachy N.
Eze, Obiechina C.
Onyekpa, Johnson I.
Ofor, Ifeanyichukwu J.
Onah, Osmond O.
Omeje, Chimdalu U.
Ezike, Andre U.
Enyinna, Perpetua K.
Malachy, Divinefavour E.
Okafor, Chigozie G.
author_facet Awkadigwe, Fredrick I.
Ezugwu, Frank O.
Eleje, George U.
Nweze, Sylvester O.
Odugu, Boniface U.
Dinwoke, Victor O.
Olu, Ephraim A.
Ortuanya, Kelvin E.
Ezenwaeze, Malachy N.
Eze, Obiechina C.
Onyekpa, Johnson I.
Ofor, Ifeanyichukwu J.
Onah, Osmond O.
Omeje, Chimdalu U.
Ezike, Andre U.
Enyinna, Perpetua K.
Malachy, Divinefavour E.
Okafor, Chigozie G.
author_sort Awkadigwe, Fredrick I.
collection PubMed
description OBJECTIVE: To compare the effects on feto-maternal outcomes of expectant versus active management for premature rupture of membranes (PROM) at term. METHODS: This was a prospective randomized (1:1) controlled study involving 86 pregnant-women who received either expectant management (n = 43) or active management with misoprostol (n = 43) for PROM at term. Primary outcome was route of delivery. Secondary outcomes were: PROM to presentation interval; latency period; PROM to delivery interval; recruitment to delivery interval; labour and delivery complications. RESULTS: Baseline-characteristics were similar between groups. There was no significant difference between active and expectant groups in mean PROM to presentation/admission, or PROM to delivery. However, mean latency period (11.1 ± 7.3 hours vs 8.8 ± 5.5 hours) and mean recruitment to delivery intervals after PROM (14.7 ± 5.2 hours vs 11.8 ± 5.0 hours) were significantly shorter for the active group compared with the expectant group. Although the rate of caesarean section was less in expectant management group (21%) compared with the active management group (30%), the difference was not statistically significant. There were no significant differences between groups in delivery or perinatal complications. CONCLUSION: Active and expectant management for PROM at term gave comparable outcomes in terms of methods of delivery and complications. However, active management significantly shortened the latency period and induction to delivery intervals compared with expectant management. Trial-Registration: Pan-African-trial-registry-(PACTR)-approval-number PACTR202206797734088
format Online
Article
Text
id pubmed-10478565
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-104785652023-09-06 Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study Awkadigwe, Fredrick I. Ezugwu, Frank O. Eleje, George U. Nweze, Sylvester O. Odugu, Boniface U. Dinwoke, Victor O. Olu, Ephraim A. Ortuanya, Kelvin E. Ezenwaeze, Malachy N. Eze, Obiechina C. Onyekpa, Johnson I. Ofor, Ifeanyichukwu J. Onah, Osmond O. Omeje, Chimdalu U. Ezike, Andre U. Enyinna, Perpetua K. Malachy, Divinefavour E. Okafor, Chigozie G. J Int Med Res Prospective Clinical Research Report OBJECTIVE: To compare the effects on feto-maternal outcomes of expectant versus active management for premature rupture of membranes (PROM) at term. METHODS: This was a prospective randomized (1:1) controlled study involving 86 pregnant-women who received either expectant management (n = 43) or active management with misoprostol (n = 43) for PROM at term. Primary outcome was route of delivery. Secondary outcomes were: PROM to presentation interval; latency period; PROM to delivery interval; recruitment to delivery interval; labour and delivery complications. RESULTS: Baseline-characteristics were similar between groups. There was no significant difference between active and expectant groups in mean PROM to presentation/admission, or PROM to delivery. However, mean latency period (11.1 ± 7.3 hours vs 8.8 ± 5.5 hours) and mean recruitment to delivery intervals after PROM (14.7 ± 5.2 hours vs 11.8 ± 5.0 hours) were significantly shorter for the active group compared with the expectant group. Although the rate of caesarean section was less in expectant management group (21%) compared with the active management group (30%), the difference was not statistically significant. There were no significant differences between groups in delivery or perinatal complications. CONCLUSION: Active and expectant management for PROM at term gave comparable outcomes in terms of methods of delivery and complications. However, active management significantly shortened the latency period and induction to delivery intervals compared with expectant management. Trial-Registration: Pan-African-trial-registry-(PACTR)-approval-number PACTR202206797734088 SAGE Publications 2023-09-01 /pmc/articles/PMC10478565/ /pubmed/37656970 http://dx.doi.org/10.1177/03000605231195451 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Prospective Clinical Research Report
Awkadigwe, Fredrick I.
Ezugwu, Frank O.
Eleje, George U.
Nweze, Sylvester O.
Odugu, Boniface U.
Dinwoke, Victor O.
Olu, Ephraim A.
Ortuanya, Kelvin E.
Ezenwaeze, Malachy N.
Eze, Obiechina C.
Onyekpa, Johnson I.
Ofor, Ifeanyichukwu J.
Onah, Osmond O.
Omeje, Chimdalu U.
Ezike, Andre U.
Enyinna, Perpetua K.
Malachy, Divinefavour E.
Okafor, Chigozie G.
Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title_full Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title_fullStr Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title_full_unstemmed Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title_short Active versus expectant management for premature rupture of membranes at term: A randomized, controlled study
title_sort active versus expectant management for premature rupture of membranes at term: a randomized, controlled study
topic Prospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478565/
https://www.ncbi.nlm.nih.gov/pubmed/37656970
http://dx.doi.org/10.1177/03000605231195451
work_keys_str_mv AT awkadigwefredricki activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT ezugwufranko activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT elejegeorgeu activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT nwezesylvestero activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT odugubonifaceu activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT dinwokevictoro activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT oluephraima activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT ortuanyakelvine activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT ezenwaezemalachyn activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT ezeobiechinac activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT onyekpajohnsoni activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT oforifeanyichukwuj activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT onahosmondo activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT omejechimdaluu activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT ezikeandreu activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT enyinnaperpetuak activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT malachydivinefavoure activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy
AT okaforchigozieg activeversusexpectantmanagementforprematureruptureofmembranesattermarandomizedcontrolledstudy